Report overview
This report contains market size and forecasts of Recombinant Protein Drugs in global, including the following market information:
Global Recombinant Protein Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Protein Drugs Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Recombinant Protein Drugs companies in 2021 (%)
The global Recombinant Protein Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Recombinant DNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Protein Drugs include Novo Nordisk, Amgen, Sanofi, Eli Lilly, Merck Serono, Ortho Biotech, Roche, Kyowa Hakko Kirin and Pharmingen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Protein Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Protein Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Recombinant Protein Drugs Market Segment Percentages, by Type, 2021 (%)
Recombinant DNA
Recombinant RNA
Global Recombinant Protein Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Recombinant Protein Drugs Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical Industry
Others
Global Recombinant Protein Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Recombinant Protein Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Protein Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Protein Drugs revenues share in global market, 2021 (%)
Key companies Recombinant Protein Drugs sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Recombinant Protein Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono
Ortho Biotech
Roche
Kyowa Hakko Kirin
Pharmingen
Abcam
GenSci
SL PHARM
Dongbao Pharm
Ankebio
NCPC
Heng Rui
